European Commission approves new contract for a potential COVID-19 vaccine with Novavax (NVAX)
Go back to European Commission approves new contract for a potential COVID-19 vaccine with Novavax (NVAX)| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $9.23 | |||
| Open | $8.81 | 52 Week Low | $1.16 | |||
| Day High | $9.59 | P/E | N/A | |||
| Day Low | $8.81 | EPS | $-0.30 | |||
| Volume | 4,235,734 | |||||
